Medical Materiel/Medical Biological Defense Equipment - Eng Dev

Abstract

This Program Element (PE) funds advanced development of medical materiel within the System Demonstration and Low Rate Initial Production portions of the acquisition life cycle using Budget Activity 6.5 (System Development and Demonstration) funding. It supports products successfully developed in the Systems Integration portion of the Systems Development and Demonstration phases through completion of the Milestone C Decision Review. Commercially-off-the-shelf (COTS) medical products are also tested and evaluated for military use, when available. This PE primarily includes pivotal (conclusive) human clinical trials necessary for licensure by the Food and Drug Administration (FDA). Projects in this PE include the following: Project 832 funds the engineering and manufacturing development of medical products for enhanced combat casualty care and follow-on care, including rehabilitation. Mature COTS medical products are also evaluated for military use. Consideration will also be given to reduce the medical sustainment footprint through smaller weight and cube volume, or equipment independence from supporting materiel. Products from this project will normally transition to OPA Funds. Project 849 funds development of candidate medical countermeasures for military relevant infectious diseases. These products fall in four major areas: vaccines, drugs, diagnostic kits/devices, and insect control measures to limit exposure and disease transmission. FDA approval is a mandatory obligation for all military products placed into the hands of medical providers or service members for human use. Products from this project will normally transition to DoD Health Programs or OPA funds. These Projects are managed by United States (U.S.) Army Medical Materiel Development Activity (USAMMDA) of the U.S. Army Medical Research and Development Command.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2023
Source ID
0604807A_5_2040_PB_2023
Change Summary Explanation
FY 2023 funding increase reflects the fact that the FY 2022 President's Budget request did not include out-year funding.
Service Agency Name
Army

Entities

Organizations

  • United States Army

Tags

DTIC Thesaurus Topics

  • Acquisition
  • Biomedical Research
  • Brain Injuries
  • Clinical Trials
  • Combat Casualty Care
  • Cost Analysis
  • Health Services
  • Hiv Infections
  • Infectious Diseases
  • Military Hospitals
  • Military Medicine
  • National Security
  • Product Development
  • Systems Engineering
  • Test And Evaluation
  • United States
  • Vaccines

Fields of Study

  • Medicine

Readers

  • Infectious Disease/Epidemiology
  • Medical or Health Care Field.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents